App aims to help diabetes patients protect kidneys through diet

NCT ID NCT07485075

Recruiting now Disease control Sponsor: Steno Diabetes Center Copenhagen Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a smartphone app called StenoFood that gives dietary advice and self-monitoring tools to people with type 2 diabetes and early kidney disease. The goal is to see if the app helps them follow low-sodium and moderate-protein diet guidelines. About 104 participants will use the app for 6 months, and researchers will measure changes in salt and protein intake through urine tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: StenoFood App (digital patient education program with dietary guidance and self-monitoring tools)
What this could lead to: If successful, this app could become a simple, scalable tool to help people with type 2 diabetes and kidney disease stick to recommended diets, potentially slowing kidney decline.
What could go wrong: This is a small, early-stage study (104 participants) focused on dietary adherence, not hard outcomes like kidney failure. The app may not improve health or be easy for everyone to use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome impaired renal function disease kidney disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES TYPE 2 KIDNEY DISEASE

Contacts and locations

Locations

Nordsjællands Hospital, Hillerød
RECRUITING

Hillerød, Captial Region of Denmark, 3400, Denmark
Steno Diabetes Center Copenhagen,
RECRUITING

Herlev, Captial Region of Denmark, 2730, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.